Tumor suppressor and hepatocellular carcinoma
- 1 January 2008
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (11) , 1720-1733
- https://doi.org/10.3748/wjg.14.1720
Abstract
A few signaling pathways are driving the growth of hepatocellular carcinoma. Each of these pathways possesses negative regulators. These enzymes, which normally suppress unchecked cell proliferation, are circumvented in the oncogenic process, either the over-activity of oncogenes is sufficient to annihilate the activity of tumor suppressors or tumor suppressors have been rendered ineffective. The loss of several key tumor suppressors has been described in hepatocellular carcinoma. Here, we systematically review the evidence implicating tumor suppressors in the development of hepatocellular carcinoma.Keywords
This publication has 194 references indexed in Scilit:
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiationJournal of Hepatology, 2006
- Downregulation of miR‐122 in the rodent and human hepatocellular carcinomasJournal of Cellular Biochemistry, 2006
- Hint2, A Mitochondrial Apoptotic Sensitizer Down-Regulated in Hepatocellular CarcinomaGastroenterology, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- Targeting the p53–MDM2 interaction to treat cancerBritish Journal of Cancer, 2004
- Small molecules that reactivate mutant p53European Journal Of Cancer, 2003
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998